Maju Mathew Koola, MD | Psychiatrist.com

COVID-19–Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine

Case Report

COVID-19–Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine

November 17, 2022

This case highlights the successful use of amantadine in benzodiazepine-resistant catatonia associated with COVID-19 infection.

Joan Oh, Katrina Amber-Monta, Syed Ammar, et al

Therapeutic Efficacy of Rhemercise in Opioid Use Disorder

Original Research

Therapeutic Efficacy of Rhemercise in Opioid Use Disorder

February 10, 2022

Rhemercise is a novel mindfulness technique used to prevent relapse in opioid use disorder (OUD). This study assessed the efficacy of rhemercise as an adjunctive therapy in patients with...

Deepam Kundal, Rajnish Raj, Rohit Garg, et al

Delirium in Zonisamide-Induced Toxic Epidermal Necrolysis

Case Report

Delirium in Zonisamide-Induced Toxic Epidermal Necrolysis

February 3, 2022

The authors of this report present a case of zonisamide-induced toxic epidermal necrolysis complicated by delirium with psychosis.

Samuel Reinfeld, Christina I. Tejeda, Maju Mathew Koola

Case Report

Loperamide Addiction Treated With Buprenorphine/Naloxone

July 3, 2019

Loperamide abuse has increased in recent years. Read about a patient with excessive loperamide use who was successfully managed with buprenorphine/naloxone.

Sajoy P. Varghese, Pooja Kumari, Heshan Wijegunaratne, et al

Article

Child Abuse and Suicide Risk in Veterans

August 23, 2018

Is childhood physical and sexual abuse a significant predictor of suicide risk in veterans? This article examined this question and found the best predictors of suicide in this population....

Maju Mathew Koola, Anthony O. Ahmed, Joseph Sebastian, et al

Article

Galantamine-Memantine for Cognitive Impairments

March 1, 2018

Cognitive impairments due to electroconvulsive therapy, traumatic brain injury, and neurologic and psychiatric disorders are prevalent. Could the galantamine-memantine combination significantly improve socio-occupational functioning in these patients? Read this...

Maju Mathew Koola

Letter to the Editor

Substance Use and Cannabis Withdrawal

September 1, 2016

Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...

Maju Mathew Koola, Deanna L. Kelly, Robert P. McMahon, et al

Article

Clinical Variables and Arterial Compliance in Veterans

June 9, 2016

Reduced peripheral arterial compliance (PAC) is seen in patients with psychiatric diagnoses and has been associated with increased risk for stroke, myocardial infarction, and mortality. In this pilot study,...

Maju Mathew Koola, John D. Sorkin, Molly Fargotstein, et al

Review Article

Association of Ophthalmologic Disorders and Depression in the Elderly: A Review of the Literature

August 20, 2015

The strongest association between ophthalmologic disorders and psychiatry is depression. It's been shown that vision loss can nearly double the risk of depression. Read this review article to become...

Scott McCusker, Maju Mathew Koola

Letter to the Editor

A Case of Electroconvulsive Therapy-Resistant Depression Responding to Multiple Dopaminergic Medications

April 30, 2015

Maju Mathew Koola, Jan A. Fawcett

Letter to the Editor

Fludrocortisone in Posttraumatic Stress Disorder: Effective for Symptoms and Prazosin-Induced Hypotension

December 4, 2014

Mansi Vaishnav, Vanessa Patel, Sajoy P. Varghese, et al

Letter to the Editor

Naltrexone and Prazosin Combination for Posttraumatic Stress Disorder and Alcohol Use Disorder

August 15, 2014

Hamid Qazi, Heshan Wijegunaratne, Ravi Savajiyani, et al